Endotoxemia associated with experimentally induced multiple portosystemic shunts in dogs

American Journal of Veterinary Research

Volumn 58, Issue 1, 1997, Pages 83-88

  Howe, Lisa M ^a   Boothe, Dawn M ^a   Boothe, Harry W ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLNITROSAMINE; ENDOTOXIN; MUTAGENIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOG; DOG DISEASE; ENDOTOXEMIA; FEMALE; LIVER DISEASE; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTOSYSTEMIC ANASTOMOSIS; RANDOMIZATION; TIME; VETERINARY MEDICINE;

ANIMALS; BLOOD PRESSURE; DIMETHYLNITROSAMINE; DOG DISEASES; DOGS; ENDOTOXEMIA; ENDOTOXINS; FEMALE; LIVER DISEASES; MALE; MUTAGENS; PORTASYSTEMIC SHUNT, SURGICAL; RANDOM ALLOCATION; SURGERY, VETERINARY; TIME FACTORS;

EID: 0030640777     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Whiting PG, Peterson SL. Portosystemic shunts. In: Slatter D, ed. Textbook of small animal surgery. 2nd ed. Philadelphia: WB Saunders Co, 1993;660-677.
2. Butler LM, Fossum TW, Boothe HW. Surgical management of extrahepatic portosystemic shunts in the dog and cat. Semin Vet Med Surg (Small Anim) 1990;5:127-133.
3. Butler-Howe LM, Boothe HW Jr, Boothe DM, et al. Effects of vena caval banding in experimentally induced multiple portosystemic shunts in dogs. Am J Vet Res 1993;54:1774-1783.
4. Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994;8:217-225.
5. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Immunol 1995;13:437-457.
6. VanDeventer SJH, TenCate JW, Tytgat GN. Intestinal endotoxemia: clinical significance. Gastroenterology 1988:94;825-831.
7. Nolan JP, Camara DS. The importance of intestinal endotoxins in liver disease. Bacterial endotoxins: structure, biomedical significance, and detection with the Limulus amebocyte lysate test. New York: Alan R Liss Inc, 1985;347-364.
8. Landow L, Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994;38:626-639.
9. Mathison JC, Ulevitch RJ. The clearance, tissue distribution and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133-2143.
10. Tarao K, So K, Moroi T, et al. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance. Gastroenterology 1977;73:539-542.
11. Boothe DM, Jenkins WL, Green RA, et al. Dimethylnitrosamine-induced hepatotoxicosis in dogs as a model of progressive canine hepatic disease. Am J Vet Res 1992;53:411-420.
12. Madden JW, Gertmann PM, Peacock EE. Dimethylnitrosamine-induced hepatic cirrhosis: a new canine model of an ancient human disease. Surgery 1970;68:260-268.
13. Boothe DM, Brown SA, Jenkins WL, et al. Indocyanine green disposition in healthy dogs and dogs with mild, moderate, or severe dimethylnitrosamine-induced hepatic disease. Am J Vet Res 1992;53:382-388,
14. Johnson SE. Portal hypertension. Part I. Pathophysiology and clinical consequences. Compend Contin Educ Pract Vet 1987;9:741-750.
15. Salzer WL, McCall CE. The biochemistry of endotoxin. Mol Aspects Med 1988;10:511-629.
16. Bourgoignie JJ, Valle GA. Endotoxin and renal function in liver disease. In: Epstein M, ed. The kidney in liver disease. 3rd ed. Baltimore: The Williams & Wilkins Co, 1988;486-507.
17. Bradfield JWB. Control of spillover. The importance of Kupffer cell function in clinical medicine. Lancet 1974;2:883-886.
18. Prytz H, Holst-Christensen J, Korner B, et al. Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol 1976;11:857-863.
19. Gans H. RES control of endotoxemia. In: Richard SM, Filkins JP, eds. The reticuloendothelial system: a comprehensive treatise. Vol 7A. New York: Plenum Press, 1985;115-143.
20. Nakao A, Shigemi T, Yasunori K, et al. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology 1994;19:1251-1253.
21. Aoki H, Nakao A. Experimental study of intrinsic endotoxemia in liver cirrhosis rats. Jpn J Gastroenterol 1987;84:1103-1109.
22. Van Vliet ACM, Maas HCM, Wilson JHP. The effect of portasystemic shunting and RES function on endotoxemia in human liver disease. In: Liehr H, Grun M, eds. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam: Elsevier, 1980;159-164.
23. Graudal N, Milman N, Kirkegaard E, et al. Bacteremia in cirrhosis of the liver. Liver 1986;6:297-301.
24. Peterson SL, Koblik PD, Whiting PG, et al. Endotoxin concentrations measured by a chromogenic assay in portal and peripheral venous blood in ten dogs with portosystemic shunts. J Vet Intern Med 1991;5:71-74.
25. Thompson JN, Cohen J, Moore RH, et al. Endotoxemia in obstructive jaundice: observations on cause and clinical significance. Am J Surg 1988;155:314-321.
26. Bottoms GD, Gimarc S, Pfeifer C. Plasma concentrations of endotoxin following jugular or portal injections of endotoxin and following gastrointestinal ischemia due to hemorrhage. Circ Shock 1991;33:1-6.
27. Wessels BC, Gaffin SL, Wells MT. Circulating plasma endotoxin (lipopolysaccharide) concentrations in healthy and hemorrhage enteric dogs: antiendotoxin immunotherapy in hemorrhagic enteric endotoxemia. J Am Anim Hosp Assoc 1987;23:291-295.
28. Wessels BC, Wells MT. Antiendotoxin immunotherapy for canine pyometra endotoxemia. J Am Anim Hosp Assoc 1989;25:455-460.
29. Berzofsky RN. The preparation of a control standard endotoxin to be used in both the gel-clot and chromogenic Limulus amebocyte lysate test. In: Watson SW, Levin J, Novitsky TJ, eds. Detection of bacterial endotoxins with the Limulus amebocyte lysate test. New York: Alan R Liss Inc, 1987;183-188.
30. Novitsky TJ, Remillard JF, Loy N. Design criteria and evaluation of the LAL-4000 for kinetic turbidometric LAL assay. In: Watson SW, Levin J, Novitsky TJ, eds. Detection of bacterial endotoxins with the Limulus amebocyte lysate test. New York: Alan R Liss Inc, 1987:189-196.
31. Dawson ME. Endotoxin standards and CSE potency. LAL Update 1993;11:2-5.
32. Novitsky TJ. Potency, certificates of analysis and international standards. LAL Update 1994;12:1-3.
33. Eng RHD, Smith SM, Fan-Havard P, et al. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Inject Dis 1993;16:185-189.
34. Prins JM, VanDeventer SJH, Kuijper EJ, et al. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994;38:1211-1218.
35. Jackson JJ, Kropp H. Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992;165:1033-1041.